Court orders NuVasive to pay $60M in damages over trademark use

10/28/2010 | Reuters

A U.S. district court ordered NuVasive to pay Neurovision Medical Products $60 million in damages in a case over NuVasive's use of the NeuroVision trademark for a spinal-surgical product. NuVasive said it plans to appeal the ruling, and that the damages amount could change.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Foster City, CA
Sr. Compliance Director Ethics and Compliance
Fridley, MN
Product Patent Attorney
Foster City, CA
Employment Counsel
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC